Raptor Pharmaceuticals Revenue, Growth & Competitor Profile

DBA RAPTOR PHARMACEUTICAL, INC

Company Profile & Annual Report for Raptor Pharmaceuticals

Access the complete profile.

Raptor Pharmaceuticals Fast Facts

Revenue	N/A    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	7 Hamilton Landing Suite 100 Novato, CA 94949

Note: Revenues for privately held companies are statistical evaluations.


Raptor Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Raptor Pharmaceuticals's annual revenues are N/A (see exact revenue data)
• What industry is the company in?
  • Raptor Pharmaceuticals is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Trademark Applications

Trademark applications show the products and services that Raptor Pharmaceuticals is developing and marketing. Raptor Pharmaceuticals doesn't have any recent trademark applications, indicating Raptor Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SIRONEX PS Medical information; Providing health information; Providing medical information in the field of cystinosis; Providing medical information in the field of pediatric NASH; Providing medical information in the field of Huntington's disease; Providing medical information in the field of Leigh's syndrome; Providing medical information in the field of mitochondrial disorders; Providing on-line information, news and commentary in the field of health and wellness relating to neurological diseases and disorders	06/04/2015
BYDENAF Pharmaceutical preparations for treating genetic disorders; pharmaceutical preparations for treating neurological disorders; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating Huntington's disease and related disorders; pharmaceutical preparations for treating fibrotic disorders; pharmaceutical preparations for treating mitochondrial disease; and pharmaceutical preparations for treating NAFLD and NASH disease and related disorders	01/20/2015

See all trademarks and details in the Full Report.

Market Share of Raptor Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Raptor Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Raptor Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BIOSEARCH TECHNOLOGIES	Petaluma, CA	100
BUCK INSTITUTE FOR RESEARCH ON AGING	Novato, CA	85
FULL CIRCLE AUTOMOTIVE	Rohnert Park, CA	34
EKSO BIONICS	San Rafael, CA	22
GLOBAL COALITION FOR ADAPTIVE RESEARCH	Larkspur, CA	13
BIT BIO	Corte Madera, CA	13

Future Competition: Raptor Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Raptor Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)